The Role of Digestive Microflora and Probiotics in Inflammatory Bowel Disease

References

• Sartor RB. Enteric microflora in IBD: pathogens or commen-sal? Inflam Bowel Dis 1997; 3: 230–5.
   PubMed Web of Science ®Google Scholar
• Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174–93.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Adami HO. The epidemiology of inflammatory bowel disease. In: Current Topics in Gastroenterology. Infl-ammatory Bowel Disease (MacDermott RP, Stenson WF eds), Elsevier, New York, 1, 1992.
   Google Scholar
• Chadwick VS, Chen W. The intestinal microflora and inflam-matory bowel disease. In: Medical Importance of the Normal Microflora (Tannock GW ed), Kluwer Academic Publishers, Dordrecht, The Netherlands, 177–221, 1999.
   Google Scholar
• Koletzko S, Griffiths A, Corey M, et al. Infant feeding practices and ulcerative colitis in childhood. BMJ 1991; 302: 1580–1.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Adami HO, Helmick CG, et al. Perinatal risk factors for inflammatory bowel disease: a case-controlled study. Am J Epidemiol 1990; 132: 1111–9.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, D'Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251–3.
   PubMed Web of Science ®Google Scholar
• Dijkstra B, Bagshaw PF, Friselle FA. Appendectomy protects against ulcerative colitis even when controlling for cigarette smoking. Dis Colon Rectum 1999; 42: 334–6.
   Google Scholar
• Sanderson JD, Moss MT, Tizard ML, et al. Mycobacterium paratuberculosis DNA found in Crohn's disease tissue. Gut 1992; 33: 890–6.
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Neut C, Bamich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115: 1405–13.
   Google Scholar
• Sartor RB, Rath HC, Senon RK, et al. Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 1996; 12: 327–33.
   Web of Science ®Google Scholar
• Rhodes JM. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces to-gether with sugar. Lancet 1996; 347: 40–4.
   PubMed Web of Science ®Google Scholar
• Bamba T, Matsuda H, Endo M, et al. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gas-troenterol 1995; 30 (Suppl 8): 45–7.
   PubMedGoogle Scholar
• Kallinowski F, Wassmer A, Hofmann MA, et al. Prevalence of enteropathogenic bacteria in surgicaly treated chronic infl-ammatory bowel disease. Hepatogastroenterology 1998; 45: 1552–8.
   PubMedGoogle Scholar
• Walmsey R S, Anthony A, Slim R, et al. Absence of Es-cherichia coli, Listeria moncytogenes, and Klebsiella pneu-monae antigens within inflammatory bowel disease tissues. J Clin Pathol 1998; 51: 657–61.
   Web of Science ®Google Scholar
• Burke D, Axon A. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ 1988; 297: 102–4.
   PubMed Web of Science ®Google Scholar
• Burke DA, Axon ATR Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol 1987; 40: 782–6.
   PubMed Web of Science ®Google Scholar
• Hartley MG, Hudson MJ, Swarbrick ET, et al. Adhesive and hydrophobic properties of Escherichia coli from the rectal mucosa of patients with ulcerative colitis. Gut 1993; 34: 63–7.
   PubMed Web of Science ®Google Scholar
• Schultsz C, Moussa M, van Ketel R, et al. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol 1997; 50: 573–9.
   PubMed Web of Science ®Google Scholar
• Von Wulffen H, Riissmann H, Karch H, et al. Verocytoxin-producing Escherichia coli 02:H5 isolated from patients with ulcerative colitis. Lancet 1989; I: 1449–50.
   Google Scholar
• Schultsz C, van den Berg FM, ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbours numbers of bacteria compared with controls. Gastroenterology 1999; 117: 1089–97.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis. Inflam Bowel Dis 1995; 1: 64–75.
   Google Scholar
• Rath HC, Ikeda JS, Linde H-J, et al. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1999; 116: 310–9.
   Google Scholar
• Sutherland L, Singleton J, Sessions J. Double-blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991; 32: 1071–5.
   Google Scholar
• Rutgeerts P, Geboes K, Peeters M, et al. Effect of faecal stream divertion on recurrence of Crohn's disease in the neotenninal ileum. Lancet 1991; 338: 771–4.
   PubMed Web of Science ®Google Scholar
• Keighley MRB. Review article: the management of pouchitis. Aliment Pharmacol Ther 1996; 10: 449–57.
   PubMed Web of Science ®Google Scholar
• D'Haens GR, Geboes K, Peeters M, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infu-sion of intestinal contents in excluded ileum. Gastroenterol-ogy 1998; 114: 262–7.
   PubMed Web of Science ®Google Scholar
• Klasen IS, Melief MJ, Van Halteren AGS, et al. The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease. Clin Immunol Immunopathol 1994; 71: 303–8.
   Google Scholar
• Wellemann W, Flink P, Benner F, et al. Endotoxinaemia in active Crohn's diseas. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 1986; 27: 177–81.
   Google Scholar
• Sartor RB. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflam-mation. In: Inflammatory bowel disease (Kirsner JB, Shorter RG eds), 4th edition, Williams & Wilkins, Baltimore, USA, 1995, 96–124.
   Google Scholar
• Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resi-dent intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448–55.
   Google Scholar
• Macpherson A, Koo UY, Forgacs I, Philpott-Howard J, Bjamason I. Mucosal antibodies in inflammatory bowel dis-ease are directed against intestinal bacteria. Gut 1996; 38: 365–75.
   Google Scholar
• Chester JF, Ross JS, Malt RA, et al. Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol 1985; 121: 284–6.
   PubMed Web of Science ®Google Scholar
• LeDuc LE, Nast CC. Chemotactic peptide-induced acute colitis in rabbits. Gastroenterology 1990; 98: 929–35.
   PubMed Web of Science ®Google Scholar
• Von Ritter C, Sekizuka E, Grisham MB, et al. The chemotac-tic peptide N-formyl methionyl-leucyl-phenylalanineincreases mucosal permeability in the distal ileum of the rat. Gastroen-terology 1988; 95: 651–6.
   PubMed Web of Science ®Google Scholar
• Granger DN, Zimmerman BJ, Sekizuka E, et al. Intestinal microvascular exchange in the rat during luminal perfusion with formyl-methionyl-leucyl-phenylalanine. Gastroenterol-ogy 1988; 94: 673–6.
   PubMed Web of Science ®Google Scholar
• Hobson CH, Butt TJ, Ferry DM, et al. Enterohepatic circula-tion of bacterial chemotactic peptides in rats with experimen-tal colitis. Gastroenterology 1988; 94: 1006–13.
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Mellor DM, Myers DB, et al. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol 1988; 23: 121–8.
   PubMed Web of Science ®Google Scholar
• Woodhouse AF, Anderson RP, Myers DB, et al. Intestinal absorption, metabolism and effects of bacterial chemotactic peptides in rat intestine. J Gastroenterol Hepatol 1987; 2: 35–40.
   Web of Science ®Google Scholar
• Ferry DM, Butt TJ, Broom MF, et al. Bacterial chemotactic oligopeptides and the intestinal mucosa barrier. Gastroen-terology 1989; 97: 61–7.
   PubMed Web of Science ®Google Scholar
• Wells C, Maddaus MA, Simmons RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 1988; 10: 958–64.
   PubMedGoogle Scholar
• Ambrose NS, Johnson M, Burdon DW, et al. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn' disease surgery. Br J Surg 1984; 71: 623–5.
   PubMed Web of Science ®Google Scholar
• Laffineur G, Lescut D, Vmcent P, et al. Translocation bacte-rienne dans la maladie de Crohn. Gastroenterol Clin Biol 1992; 16: 777–81.
   PubMedGoogle Scholar
• Ohkusa T, Okayasu I, Tokoi S, et al. Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hep-atol 1993; 8: 116–8.
   PubMed Web of Science ®Google Scholar
• Kreuzpaintner G, Horstkotte D, Heyll A, et al. Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med 1992; 92: 391–5.
   Web of Science ®Google Scholar
• Onderdonk AB, Bartlett JG. Bacteriological studies of experi-mental ulcerative colitis. Am J Nutr 1979; 32: 258–63.
   PubMed Web of Science ®Google Scholar
• Roediger WER, Heyworht M, Willoughby P, et al. Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol 1982; 35: 323–6.
   PubMed Web of Science ®Google Scholar
• Benno P, Leijonmarck CE, Monsen U, et al. Functional alterations of the microflora in patients with ulcerative colitis. Scand J Gastroenterol 1993; 28: 839–44.
   PubMed Web of Science ®Google Scholar
• Pitcher M, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 1996; 39: 1–4.
   PubMed Web of Science ®Google Scholar
• Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793–8.
   PubMed Web of Science ®Google Scholar
• Roediger WEW. Reducing sulfur compounds of the colon impairs colonocyte nutrition: implications for ulcerative coli-tis. Gastroenterology 1993; 104: 802–9.
   PubMed Web of Science ®Google Scholar
• Chapman M, Grahn M, Boyle M, et al. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1993; 35: 73–7.
   Web of Science ®Google Scholar
• Latella G. Effects of SCFA on human colonocytes. Gastroen-terol Int 1998; 11 (Suppl. 1): 76–9.
   Google Scholar
• Sakata T, Kojima T, Fujieda M, Miyakozawa M, Takahashi M, Ushida K. Probiotic preparations dose-dependently in-crease net production rates of organic acids and decrease that of ammonia by pig cecal bacteria in batch culture. Dig Dis Sci 1999; 44: 1485–93.
   PubMed Web of Science ®Google Scholar
• Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to the pathogenesis or a possible thera-peutic alternative? Gastroenterology 1999; 116: 1246–60.
   PubMed Web of Science ®Google Scholar
• Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut 2000 (in press).
   Google Scholar
• Fabia R, Ar'Rajab A, Johansson ML, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993; 54: 248–55.
   Google Scholar
• Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal fl-D-galactosidase production and bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997; 42: 817–22.
   PubMed Web of Science ®Google Scholar
• Ruseler-van-Embden JGH, Schouten WR, van Lieshout LMC. Pouchitis: result of microbial imbalance? Gut 1994; 35: 658–64.
   Google Scholar
• Madsen KL, Doyle JS, Jewell LD, Tavemini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999; 116: 1107–14.
   Google Scholar
• Videla S, Villaseca J, Garcia-Lafuente A et al. Dietary inulin prevents distal colitis induced by dextran sulfate sodium (DSS). Gastroenterology 1998; 114: A1110 (abstract)
   Google Scholar
• Meijer HP, Welters CFM, Heineman E et al. Effect of enteral inulin on the pouch disease activity index and on epithelial gene expression within the ileoanal pouch: a randomized, placebo-controlled crossover study. Gastroenterology 1998; 114: A397 (abstract)
   Google Scholar
• Rembacken BJ, Snelling AM, Hawkey PM, Axon ATR. A double blind trial of non pathogenic E. coli vs mesalazine for the treatment of ulcerative colitis. Gut 1997; 41 (Suppl. 3): 3911–5.
   Google Scholar
• Kruis W, Schuts E, Fric P, Fixa B, Judmaier G, Stolle M. Double-blind comparison of an oral Escherichia coli prepara-tion and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 853–8.
   PubMed Web of Science ®Google Scholar
• Mackowiak PA. The normal microbial flora. N Engl J Med 1982; 307: 83–93.
   PubMed Web of Science ®Google Scholar
• Bengmark S. Econutrition and health maintenance. A new concept to prevent GI inflammation, ulceration and sepsis. Clin Nutr 1996; 15: 1–10.
   Google Scholar
• Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the faecal flora by a new probiotic prepa-ration: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103–8.
   PubMed Web of Science ®Google Scholar
• Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996; 40: 137–45.
   PubMed Web of Science ®Google Scholar
• Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH. Ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998; 85: 800–3.
   Google Scholar
• Sanborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856–60.
   Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9.
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Cifone G et al. In-vivo effect of a highly concentrated probiotic on IL-10 pelvic pouch tissue levels. Gastroenterology 1999; 116: A723. (abstract)
   Google Scholar
• Chen T, Isomaki P, Rimpilainen M, Toivanen P. Human cyto-kine responses induced by Gram-positive cell walls of normal intestinal microbiota. Clin Exp Immunol 1999; 118: 261–7.
   PubMed Web of Science ®Google Scholar